News

Kidney Cancer Program to celebrate 10th anniversary with faculty symposium

March 8, 2023

Announcement

Discovery, Education, Events

Dr. Janie Qin receives $1M Frenkel Endowed Scholar Award

May 9, 2022

Announcement

Clinical Trial, Discovery, HIF2, Targeted Drugs, Technology Development

International partnership evaluates UTSW-developed approach to locally advanced kidney cancer

April 28, 2022

Spotlight

Radiation, Surgery

DoD awards $1.3 million to UTSW investigators for kidney cancer research

April 21, 2022

Recognition, Research

Discovery, Fundamental Research, Pediatric, Targeted Drugs

Pioneer in kidney cancer radiation and long-term KCP collaborator named new chair of radiation oncology

March 21, 2022

Announcement

Radiation

Higher doses of cabozantinib may offer hope to kidney cancer patients with few other options

March 15, 2022

Patient Story, Spotlight

Discovery, Targeted Drugs

CPRIT awards more than $2 million in research funding to UTSW kidney cancer investigators

February 22, 2022

Announcement, Recognition, Research

AI-Data Science, Fundamental Research

Scott Schwartzman, M.D., joins KCP as Co-Leader of Education

February 14, 2022

Announcement

CenterTimes: Addressing the most feared kidney cancer complication

January 7, 2022

Spotlight

Discovery, Patient Care, Radiation, Surgery

Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression

January 3, 2022

Research

Clinical Trial, Radiation

Maralice Conacci-Sorrell, Ph.D., named inaugural Co-Leader for Diversity, Equity, and Inclusion

December 27, 2021

Announcement

SPORE-funded kidney cancer tumorgraft platform to advance precision medicine

November 29, 2021

Research

Discovery, Immunotherapy, SPORE, Targeted Drugs